Precision BioSciences Inc (DTIL) Habari na Bei za Hisa

MwanzoDTIL • NASDAQ

Precision BioSciences Inc

$ 4.17

20 Jan, 17:20:00 GMT -5 · USD · NASDAQ · Kanusho

Bei iliyotangulia

$ 4.05

Bei za siku

$ 3.95 - $ 4.21

Bei za mwaka

$ 3.75 - $ 8.82

Thamani ya kampuni katika soko

95.48M USD

Wastani wa hisa zilizouzwa

elfu 243.92

Uwiano wa bei na mapato

Mgao wa faida

Ubadilishanaji wa msingi

NASDAQ

Habari za soko

CNBC

dakika 45 zilizopita

Stock futures tick higher after S&P 500 and Dow notch worst day since October: Live updates

S&P 500 has its worst day since October. Here's why stocks were down.

MarketWatch

saa 1 iliyopita

These stocks were the biggest losers on the S&P 500’s worst day in three months

Stock market today: Dow plummets 800 points, S&P 500, Nasdaq sink over 2% as Trump's Greenland threats clobber stocks

Two Reasons Make The Rule Of 20 Especially Misleading In 2026

Investor's Business Daily

dakika 46 zilizopita

Stock Market Dives On Trump Tariff Threats; Nasdaq, S&P 500 Break Key Level

Kuhusu

Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina. Founded in 2006, Precision is focused on developing both in vivo and ex vivo gene editing therapies using its proprietary "ARCUS" genome editing platform. Wikipedia

Ilianzishwa

2006

Tovuti

precisionbiosciences.com

Wafanyakazi